ABSTRACT
BACKGROUND AND OBJECTIVES: Spinal muscular atrophy (SMA) is a progressive neurodegenerative disease due to homozygous loss-of-function of the survival motor neuron gene SMN1 with absence of the functional SMN protein. Nusinersen, a costly intrathecally administered drug approved in 2017 in Europe, induces alternative splicing of the SMN2 gene, which then produces functional SMN protein, whose amount generally increases with the number of SMN2 gene copies. METHODS: We retrospectively collected data from consecutive wheelchair-bound adults with SMA managed at a single center in 2018-2020. The following were collected at each injection, on days 1, 14, 28, 63, 183, and 303: 32-item Motor Function Measurement (MFM) total score and D2 and D3 subscores; the Canadian Occupational Performance Measure (COPM) performance and satisfaction scores; and lung function tests. The patients were divided into two groups based on whether their MFM total score wasSubject(s)
Muscular Atrophy, Spinal
, Neurodegenerative Diseases
, Spinal Muscular Atrophies of Childhood
, Adult
, Canada
, Humans
, Muscular Atrophy, Spinal/drug therapy
, Oligonucleotides
, Retrospective Studies
, Spinal Muscular Atrophies of Childhood/drug therapy
ABSTRACT
BACKGROUND: In 2008, a study of the characteristics of hospitalised patients led to the development of a prognostic tool that distinguished three populations with significantly different 2-month survival rates. The goal of our study aimed at validating prospectively this prognostic tool in outpatients treated for cancer in terminal stage, based on four factors: performance status (ECOG) (PS), number of metastatic sites, serum albumin and lactate dehydrogenase. PATIENTS AND METHODS: PRONOPALL is a multicentre study of current care. About 302 adult patients who met one or more of the following criteria: life expectancy under 6 months, performance status ≥ 2 and disease progression during the previous chemotherapy regimen were included across 16 institutions between October 2009 and October 2010. Afterwards, in order to validate the prognostic tool, the score was ciphered and correlated to patient survival. RESULTS: Totally 262 patients (87%) were evaluable (27 patients excluded and 13 unknown score). Median age was 66 years [37-88], and women accounted for 59%. ECOG PS 0-1 (46%), PS 2 (37%) and PS 3-4 (17%). The primary tumours were: breast (29%), colorectal (28%), lung (13%), pancreas (12%), ovary (11%) and other (8%). About 32% of patients presented one metastatic site, 35% had two and 31% had more than two. The median lactate dehydrogenase level was 398 IU/l [118-4314]; median serum albumin was 35 g/l [13-54]. According to the PRONOPALL prognostic tool, the 2-month survival rate was 92% and the median survival rate was 301 days [209-348] for the 130 patients in population C, 66% and 79 days [71-114] for the 111 patients in population B, and 24% and 35 days for [14-56] the 21 patients in population A. These three populations survival were statistically different (P <0.0001). CONCLUSION: PRONOPALL study confirms the three prognostic profiles defined by the combination of four factors. This PRONOPALL score is a useful decision-making tool in daily practice.
Subject(s)
Ambulatory Care , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Decision Support Techniques , Neoplasms/drug therapy , Palliative Care , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/blood , Disease Progression , Female , France , Humans , Kaplan-Meier Estimate , L-Lactate Dehydrogenase/blood , Male , Middle Aged , Neoplasm Metastasis , Neoplasms/blood , Neoplasms/mortality , Predictive Value of Tests , Proportional Hazards Models , Prospective Studies , Reproducibility of Results , Risk Factors , Serum Albumin, Human/analysis , Time Factors , Treatment OutcomeSubject(s)
Syphilis , Humans , Rituximab/adverse effects , Syphilis/diagnosis , Syphilis/drug therapy , Syphilis SerodiagnosisABSTRACT
OBJECTIVE: Numerous guidelines have been published on the management of venous thromboembolism (VTE). However, therapeutic decision-making may prove challenging in routine clinical practice. With this in mind, multidisciplinary team (MDT) meetings have been set up in Rennes University Hospital, France. This study sought to describe the situations discussed during MDT meetings and to assess whether the meetings bring about changes in the management of these patients. MATERIALS AND METHODS: A retrospective single-center study conducted at the Rennes University Hospital included cases presented from the beginning of the MDT meetings (February 2015) up to May 2017. RESULTS: In total, 142 cases were presented in 15 MDT meetings, corresponding to a mean of 10±4 cases per meeting. Of these, 129 related to VTE patients: 33 provoked VTEs, 22 unprovoked VTEs, 49 cancer-related VTEs, and 25 unspecified VTEs. MDT meetings led to significant changes in the anticoagulation type (therapeutic, prophylactic, or discontinuation) and duration, but not in the anticoagulant choice (direct oral anticoagulants, vitamin K antagonists, heparins, etc.). CONCLUSION: Requests for MDT meetings are made for all VTE types, and these meetings have an impact on VTE management.
Subject(s)
Anticoagulants/administration & dosage , Blood Coagulation/drug effects , Clinical Decision-Making , Cooperative Behavior , Interdisciplinary Communication , Patient Care Team , Venous Thromboembolism/drug therapy , Administration, Oral , Anticoagulants/adverse effects , Drug Administration Schedule , France , Hospitals, University , Humans , Patient Selection , Retrospective Studies , Treatment Outcome , Venous Thromboembolism/diagnosis , Venous Thromboembolism/etiologyABSTRACT
Genomic instability is an early event in the transformation of human cells by SV40 and may contribute, as a mutagenic process, to the generation of the rare cells which survive crisis and yield immortal populations. We have previously reported that expression of large T antigen is responsible for induction of chromosome aberrations and aneuploidy. In the present study we have demonstrated that the amino terminal 147 amino acids of the protein are as proficient as full length T antigen for this destabilization of the cell genome. Analysis of mutants within this region indicated that T antigens defective for binding to pRB or lacking the first 127 amino acids are significantly reduced in their ability to induce aneuploidy and/or aberrations, whereas a cytoplasmic T antigen is less severely impaired. In addition, we have shown that binding of T antigen to p53 is dispensable for genome destabilization but may be required for continued proliferation of genetically aberrant cells.
Subject(s)
Amino Acids/metabolism , Antigens, Polyomavirus Transforming/metabolism , Genome, Human , Retinoblastoma Protein/metabolism , Tumor Suppressor Protein p53/metabolism , Animals , Antigens, Polyomavirus Transforming/genetics , Cell Line, Transformed , Cell Transformation, Viral , Humans , Karyotyping , Mutation , Protein Binding , RatsABSTRACT
The biopharmaceutics and pharmacokinetics of 5-phenyl-1, 2-dithiole-3-thione (5PDTT) were investigated in rabbits, after administration as a complex with sulfobutyl-ether-7-beta-cyclodextrin (SBE7-beta-CD) by intravenous and oral routes and as a micronized powder by oral route. 5PDTT had a rapid and large red blood cell partitioning that was not dependent on drug concentration either in vitro or ex vivo. The blood clearance was very high (354 +/- 131 mL/min) suggesting extrahepatic metabolism and/or nonrenal elimination and a significant volume of distribution (67 +/- 76 L). The renal clearance was 0.17% of total clearance. 5-phenyl-1,2-dithiol-3-one (5PDTO) was identified as a metabolite in blood and urine. The bioavailability of 5PDTT following administration of 5PDTT/SBE7-beta-CD complex was estimated to 41% while it was close to zero when 5PDTT was given as a micronized powder.
Subject(s)
Anticarcinogenic Agents/pharmacokinetics , Thiones/pharmacokinetics , Thiophenes/pharmacokinetics , beta-Cyclodextrins , Administration, Oral , Algorithms , Animals , Anticarcinogenic Agents/administration & dosage , Area Under Curve , Biopharmaceutics , Chromatography, High Pressure Liquid , Cyclodextrins/administration & dosage , Cyclodextrins/chemistry , Erythrocytes/drug effects , Half-Life , Injections, Intravenous , Male , Rabbits , Solubility , Thiones/administration & dosage , Thiophenes/administration & dosageABSTRACT
To increase the therapeutic index of second line hormonal treatment of breast cancer, new aromatase inhibitors have been synthetized; they belong to two groups: type I (formestane and exemestane) are steroidal irreversible and specific inhibitors, type II (anastrozole, letrozole and vorozole) are non steroidal reversible inhibitors, interfering with the aromatase heme. Several phase II and III trials demonstrated that these drugs are, at least, as active as aminoglutethimid or progestins in second line treatment, and are less toxic. Recently, an identical activity have been observed for anastrozole and tamoxifen in first line. In metastatic and adjuvant settings, large trials are ongoing to clarify the exact value of these drugs.
Subject(s)
Androstenedione/analogs & derivatives , Antineoplastic Agents, Hormonal/therapeutic use , Aromatase Inhibitors , Breast Neoplasms/drug therapy , Enzyme Inhibitors/therapeutic use , Anastrozole , Androstadienes/therapeutic use , Androstenedione/therapeutic use , Antineoplastic Agents, Hormonal/adverse effects , Chemotherapy, Adjuvant , Clinical Trials, Phase II as Topic , Clinical Trials, Phase III as Topic , Enzyme Inhibitors/adverse effects , Female , Humans , Letrozole , Nitriles/therapeutic use , Randomized Controlled Trials as Topic , Triazoles/therapeutic useABSTRACT
The authors report a case-history of lymphangiosarcoma or Stewart-Treves syndrome which occurred in a patient with posttraumatic lymphedema of the arm. He presented two recurrences after surgery which led to the decision of amputation. He is now disease free nine years after this treatment. Initially defined as "lymphangiosarcoma arising in chronic lymphedematous extremities after mastectomy for breast cancer", Stewart-Treves syndrome complicates rarely traumatic, postsurgical, postradiation, idiopathic, congenital or filarial lymphedema. Clinical diagnosis is based on nodular, purple and frequently multiple skin lesions on chronic lymphedema of the limb. A proliferating malignant endothelium with affinity for anti-factor-VIII is found on histological slides. The tumor aggressivity explains the short survival if no treatment is given. Stewart-Treves syndrome prognosis is poor, with the occurrence of multiple local recurrences and pulmonary metastasis. On account of its rarity, there is no therapeutic consensus. In localized stage, radical surgery is usually performed. Conservative treatment with complete tumour removal and postoperative radiotherapy has not been yet evaluated. In metastatic or locally advanced tumours, it is necessary to study the benefit of cytotoxic drugs like anthacyclins and ifosfamide known to be effective on soft tissue sarcomas.
Subject(s)
Arm Injuries/complications , Fractures, Bone/complications , Hand , Lymphangiosarcoma/etiology , Lymphedema/complications , Amputation, Surgical , Humans , Lymphangiosarcoma/pathology , Lymphangiosarcoma/surgery , Male , Middle Aged , Prognosis , Skin Transplantation , SyndromeABSTRACT
This study analysed the clinical profile, prognosis and consequences on left ventricular function of isolated obstructive atherosclerosis of the right coronary artery in order to establish the indications of percutaneous angioplasty. The inclusion criteria were at least one stenotic lesion greater than 75 p. 100 of a dominant or equilibrated right coronary artery and exclusion of stenosis of the other coronary vessels. A questionnaire was sent to the treating physician and to the patient to establish the actuarial survival (Cutler and Ederer's method). The average period of follow-up was 56 months (range 12 to 70 months). Seventy one patients (average age 53 years) were selected from a series of 2,675 consecutive coronary angiograms performed between 1979 and 1984 (2.7 p. 100). The incidence of previous infarction was 60 p. 100; this was located on the inferior wall in 75 p. 100, inferobasal wall in 12 p. 100 and infero-latero-basal wall in 13 p. 100. Bypass surgery was performed in 7 cases and percutaneous angioplasty in 2 cases. Sixty-two cases were managed medically. Analysis of the 71 angiographic films of the series showed in retrospect an indication for percutaneous angioplasty in 29 patients (42 p. 100 of the series). The 5 year mortality rate was 5.6 p. 100. Death was sudden in the 4 cases observed, including one on the 28th day after bypass surgery complicated by perioperative infarction.(ABSTRACT TRUNCATED AT 250 WORDS)
Subject(s)
Coronary Artery Disease/diagnosis , Adult , Aged , Coronary Artery Disease/surgery , Coronary Artery Disease/therapy , Female , Follow-Up Studies , Humans , Male , Middle Aged , PrognosisABSTRACT
UNLABELLED: The evolution of epidemiological data on hepatitis C virus infection is poorly documented and thus the impact of screening is difficult to evaluate. AIM: To study epidemiological variations based on the origin of transmission and the year of diagnosis of hepatitis C virus infection. METHODS: The files of all 1304 patients seen in the hepatology unit of the Rennes University Hospital were analyzed (retrospectively before and prospectively after October 1995) in relation to epidemiological features. RESULTS: Despite widespread screening which is the source of 60% of the diagnoses, the total number of new cases of hepatitis C infection per year has not increased. Compared to patients diagnosed in the first years following the discovery of the virus, patients recently identified were younger (42 +/- 14 years) and frequently drug addicts (40%). Aminotransaminases were normal in 20% of cases. The frequency of cirrhosis has declined (17%). There has been a decrease in the proportion of patients who undergo liver biopsy (50%) and treatment with interferon (one third of patients). CONCLUSIONS: The impact of screening on the number of newly treated patients seems to be lower than previously predicted.
Subject(s)
Hepatitis C Antibodies/analysis , Hepatitis C/epidemiology , Hepatitis C/transmission , Adult , Female , Genotype , HIV Infections/complications , Hepacivirus/genetics , Hepatitis C/complications , Hepatitis C/diagnosis , Hepatitis C, Chronic/complications , Hepatitis C, Chronic/diagnosis , Hepatitis C, Chronic/epidemiology , Humans , Male , Mass Screening , Middle Aged , Retrospective StudiesSubject(s)
Cardiomyopathy, Hypertrophic/complications , Death, Sudden, Cardiac/etiology , Heart Defects, Congenital/complications , Long QT Syndrome/complications , Tachycardia, Ventricular/complications , Arrhythmogenic Right Ventricular Dysplasia/complications , Arrhythmogenic Right Ventricular Dysplasia/diagnosis , Arrhythmogenic Right Ventricular Dysplasia/epidemiology , Cardiomyopathy, Hypertrophic/diagnosis , Cardiomyopathy, Hypertrophic/epidemiology , Diagnosis, Differential , Electrocardiography , Heart Conduction System/abnormalities , Heart Conduction System/physiopathology , Heart Defects, Congenital/diagnosis , Heart Defects, Congenital/epidemiology , Humans , Long QT Syndrome/congenital , Long QT Syndrome/diagnosis , Long QT Syndrome/epidemiology , Prevalence , Tachycardia, Ventricular/diagnosis , Tachycardia, Ventricular/epidemiology , Ventricular Fibrillation/complications , Ventricular Fibrillation/diagnosis , Ventricular Fibrillation/epidemiologySubject(s)
Community Health Services/legislation & jurisprudence , Community Health Services/methods , Enteral Nutrition/methods , Enteral Nutrition/nursing , Home Care Services/legislation & jurisprudence , Prescriptions , Enteral Nutrition/instrumentation , France , Humans , Insurance, Health , Patient Care Planning , Patient Education as Topic/methods , Patient SelectionABSTRACT
Some new generation pacemakers use an algorithm based on evoked response (ER) detection to verify beat-to-beat capture and to enable automatic adjustment of output. This is a prospective acute study of polarization signal (PS) and ER in nine currently available electrodes. Intraoperative testing of ventricular bipolar electrodes used the Autocapture (AC) algorithm. The intrinsic R wave, PS, ER, acceptance of AC function, and stimulation thresholds (STs) were obtained. Ventricular electrodes were categorized as follows: titanium nitride (TiN)-coated passive and active fixation, high impedance (HI), passive fixation (VP), iridium oxide-coated titanium (IROX) (VI), and platinum helix (PH) active fixation. Acute testing was performed in 217 patients with an average age of 74.26 years, 59.6% were men with primary pacing indication-SSS (46.3%). There were no significant differences found with respect to R wave and threshold between the various electrodes. PH active-fixation electrodes had significantly higher ER and PS than other groups including the TiN-coated active-fixation electrodes. TiN-coated electrodes (active and passive fixation) had significantly lower PS than other electrodes. As a result, TiN electrodes had a significantly higher functional rate of AC (91.7%), whereas PH had the lowest rate (0%). In conclusion, (1) polarization characteristics are significantly different for commercially available ventricular electrodes, (2) certain physical features at the tissue to electrode interface like TiN coating appears to be more important in determining PS than electrode tip size and fixation method, and (3) the current algorithm for AC requires electrodes that provide low polarization for satisfactory performance.
Subject(s)
Pacemaker, Artificial , Adult , Aged , Aged, 80 and over , Electrodes , Equipment Design , Evoked Potentials , Female , Humans , Male , Middle Aged , Prospective StudiesABSTRACT
The CD7 40-kDa glycoprotein is present on a major subset of human T cells and in the presence of phorbol esters mediates an accessory pathway of T cell activation. Hitherto, the intracellular events elicited by CD7 have been ill-defined. This report demonstrates that cross-linking of CD7 results in the formation of phosphatidic acid in the absence of phosphatidylinositol-4,5-bisphosphate metabolism and also the formation of D-3 phosphoinositides lipids which have been postulated to act as intracellular regulatory molecules. The magnitude of D-3 phosphoinositide formation was similar to that induced by CD3. Both the CD7- and CD3-induced elevation of phosphatidylinositol 3,4,5-trisphosphate approximately 5-10 fold less than that elicited by ligation of the costimulatory molecule CD28 by its counter receptor CD80. The formation of D-3 phosphoinositides following ligation of CD7 coincided with the co-association of CD7 with phosphoinositide 3-kinase, the enzyme which mediates the formation of D-3 phosphoinositide lipids. In contrast, ligation of another reported T cell accessory molecule CD5, failed to elicit formation of D-3 phosphoinositides, implying that phosphoinositide 3-kinase is not coupled to all T cell molecules with accessory functions. Since D-3 phosphoinositides have been suggested to play a pivotal role in T cell costimulatory signals induced by CD28, the results presented in this study suggest that CD7 may also influence T cell activation via this pathway.